These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
339 related items for PubMed ID: 24325576
1. Preparation, optimization and characterization of bovine lactoferrin-loaded liposomes and solid lipid particles modified by hydrophilic polymers using factorial design. Yao X, Bunt C, Cornish J, Quek SY, Wen J. Chem Biol Drug Des; 2014 May; 83(5):560-75. PubMed ID: 24325576 [Abstract] [Full Text] [Related]
6. Characterization of novel multifunctional cationic polymeric liposomes formed from octadecyl quaternized carboxymethyl chitosan/cholesterol and drug encapsulation. Liang XF, Wang HJ, Luo H, Tian H, Zhang BB, Hao LJ, Teng JI, Chang J. Langmuir; 2008 Jul 15; 24(14):7147-53. PubMed ID: 18564860 [Abstract] [Full Text] [Related]
7. Preparation and evaluation of zinc-pectin-chitosan composite particles for drug delivery to the colon: role of chitosan in modifying in vitro and in vivo drug release. Das S, Chaudhury A, Ng KY. Int J Pharm; 2011 Mar 15; 406(1-2):11-20. PubMed ID: 21168477 [Abstract] [Full Text] [Related]
8. Reversed chitosan-alginate polyelectrolyte complex for stability improvement of alpha-amylase: optimization and physicochemical characterization. Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB. Eur J Pharm Biopharm; 2007 Feb 15; 65(2):215-32. PubMed ID: 16982178 [Abstract] [Full Text] [Related]
9. Design of a pectin-based microparticle formulation using zinc ions as the cross-linking agent and glutaraldehyde as the hardening agent for colonic-specific delivery of resveratrol: in vitro and in vivo evaluations. Das S, Ng KY, Ho PC. J Drug Target; 2011 Jul 15; 19(6):446-57. PubMed ID: 20684731 [Abstract] [Full Text] [Related]
11. Effect of Membrane Surface Modification Using Chitosan Hydrochloride and Lactoferrin on the Properties of Astaxanthin-Loaded Liposomes. Qiang M, Pang X, Ma D, Ma C, Liu F. Molecules; 2020 Jan 30; 25(3):. PubMed ID: 32019205 [Abstract] [Full Text] [Related]
15. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment. Bagre AP, Jain K, Jain NK. Int J Pharm; 2013 Nov 01; 456(1):31-40. PubMed ID: 23994363 [Abstract] [Full Text] [Related]
16. Drug release property of chitosan-pectinate beads and its changes under the influence of microwave. Wong TW, Nurjaya S. Eur J Pharm Biopharm; 2008 May 01; 69(1):176-88. PubMed ID: 17980563 [Abstract] [Full Text] [Related]
18. The effect of oral administration of iron saturated-bovine lactoferrin encapsulated chitosan-nanocarriers on osteoarthritis. Samarasinghe RM, Kanwar RK, Kanwar JR. Biomaterials; 2014 Aug 01; 35(26):7522-34. PubMed ID: 24933511 [Abstract] [Full Text] [Related]
20. Optimization of the process variables of tilianin-loaded composite phospholipid liposomes based on response surface-central composite design and pharmacokinetic study. Zeng C, Jiang W, Tan M, Yang X, He C, Huang W, Xing J. Eur J Pharm Sci; 2016 Mar 31; 85():123-31. PubMed ID: 26883760 [Abstract] [Full Text] [Related] Page: [Next] [New Search]